
SEATTLE/LONDON - An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease. Final-stage trial data released ... World's first malaria vaccine works in major trial
No comments:
Post a Comment